Regional Glucose and Beta-hydroxybutyrate Use by Developing Rat Brain
Overview
Neurology
Authors
Affiliations
Rates of glucose and D-beta-hydroxybutyrate use were determined in five brain regions of 20-day-old rats. The regions studied were cerebral cortex, thalamus, striatum, cerebellum, and brain stem. The tracers for determining rates of substrate use were [3H]fluorodeoxyglucose and [3-14C]-D-beta-hydroxybutyrate. Two or five minutes after isotope administration the animals were sacrificed in a 6-kW, 2450-MHz focused microwave device. Ten minutes prior to isotope administration the animals were injected intraperitoneally with normal saline or DL-beta-hydroxybutyrate (10 mmol/kg). Blood D-beta-hydroxybutyrate levels averaged 0.21 mumol/ml in saline-injected and 3.13 mumol/ml in hyperketonemic rats. Rates of glucose utilization were significantly heterogeneous between regions in both groups: thalamus greater than cerebral cortex greater than or equal to striatum greater than brain stem greater than cerebellum. These rates were 20-35% lower in hyperketonemic rats. Rates of D-beta-hydroxybutyrate use varied significantly between regions only in the saline group, with the brain stem rate being significantly lower than that in cortex or cerebellum. Regional rates of D-beta-hydroxybutyrate use did not correlate significantly with regional rates of glucose use in either the saline or the hyperketonemic groups. Regional rates of glucose use were strongly and positively correlated between conditions, as were regional rates of D-beta-hydroxybutyrate use. Thus, in 20-day-old rats, the regional heterogeneity of brain glucose use is similar to that in adult rats. D-beta-Hydroxybutyrate use is much less regionally heterogeneous.(ABSTRACT TRUNCATED AT 250 WORDS)
The contribution of ketone bodies to basal and activity-dependent neuronal oxidation in vivo.
Chowdhury G, Jiang L, Rothman D, Behar K J Cereb Blood Flow Metab. 2014; 34(7):1233-42.
PMID: 24780902 PMC: 4083391. DOI: 10.1038/jcbfm.2014.77.
Cerebral ketone metabolism during development and injury.
Prins M Epilepsy Res. 2011; 100(3):218-23.
PMID: 22104087 PMC: 3306503. DOI: 10.1016/j.eplepsyres.2011.09.027.
Prins M, Hovda D J Neurotrauma. 2009; 26(7):1083-93.
PMID: 19226210 PMC: 2843133. DOI: 10.1089/neu.2008.0769.
Cerebral metabolic adaptation and ketone metabolism after brain injury.
Prins M J Cereb Blood Flow Metab. 2007; 28(1):1-16.
PMID: 17684514 PMC: 2857668. DOI: 10.1038/sj.jcbfm.9600543.
Prenen G, Go K, Paans A, Zuiderveen F, Vaalburg W, Kamman R Acta Neurochir (Wien). 1989; 99(3-4):166-72.
PMID: 2788974 DOI: 10.1007/BF01402328.